Neofect Co.Ltd - Asset Resilience Ratio
Neofect Co.Ltd (290660) has an Asset Resilience Ratio of 4.93% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Neofect Co.Ltd (290660) strategic asset index to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how Neofect Co.Ltd's Asset Resilience Ratio has changed over time. See 290660 net asset quality score to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Neofect Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Neofect Co.Ltd stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩3.87 Billion | 4.93% |
| Total Liquid Assets | ₩3.87 Billion | 4.93% |
Asset Resilience Insights
- Limited Liquidity: Neofect Co.Ltd maintains only 4.93% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Neofect Co.Ltd Industry Peers by Asset Resilience Ratio
Compare Neofect Co.Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medacta Group SA
SW:MOVE |
Medical Devices | 0.86% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Xiangyu Medical Co. Ltd. A
SHG:688626 |
Medical Devices | 1.53% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
Annual Asset Resilience Ratio for Neofect Co.Ltd (2016–2025)
The table below shows the annual Asset Resilience Ratio data for Neofect Co.Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.44% | ₩343.16 Million ≈ $232.56K |
₩77.79 Billion ≈ $52.72 Million |
-36.91pp |
| 2024-12-31 | 37.35% | ₩27.03 Billion ≈ $18.32 Million |
₩72.36 Billion ≈ $49.04 Million |
+4.46pp |
| 2023-12-31 | 32.89% | ₩23.59 Billion ≈ $15.99 Million |
₩71.71 Billion ≈ $48.60 Million |
+29.84pp |
| 2022-12-31 | 3.05% | ₩1.54 Billion ≈ $1.04 Million |
₩50.37 Billion ≈ $34.14 Million |
-8.00pp |
| 2021-12-31 | 11.05% | ₩5.80 Billion ≈ $3.93 Million |
₩52.54 Billion ≈ $35.61 Million |
-13.75pp |
| 2020-12-31 | 24.80% | ₩14.36 Billion ≈ $9.73 Million |
₩57.91 Billion ≈ $39.24 Million |
+5.47pp |
| 2019-12-31 | 19.33% | ₩9.09 Billion ≈ $6.16 Million |
₩47.02 Billion ≈ $31.86 Million |
-42.92pp |
| 2018-12-31 | 62.25% | ₩22.36 Billion ≈ $15.15 Million |
₩35.92 Billion ≈ $24.34 Million |
+23.74pp |
| 2017-12-31 | 38.51% | ₩3.93 Billion ≈ $2.66 Million |
₩10.21 Billion ≈ $6.92 Million |
-19.32pp |
| 2016-12-31 | 57.83% | ₩4.59 Billion ≈ $3.11 Million |
₩7.93 Billion ≈ $5.38 Million |
-- |
About Neofect Co.Ltd
Dynamic solution Co.,Ltd. researches, develops, manufactures, and sells rehabilitation medical devices and contents for stroke and spinal cord injuries. The company offers Neofect Smart Glove, a high-tech rehab device that measures movements of the forearm, wrist, and digits with accelerometer and bending sensors; Neofect Smart Kids for hand rehabilitation in children; Neofect Smart Board, a high… Read more